Romi Gupta

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1”.

PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1

Oncogene(2021)10.1038/s41388-021-01683-y

N/A

1.4DataRank · unranked

45 citations

Parmanand Malvi, Deborah Della Manna, Eddy S. Yang, Suresh Bugide, Xuchen Zhang +3 more

Roles and therapeutic targeting of ceramide metabolism in cancer

Molecular Metabolism(2024)10.1016/j.molmet.2024.101936

N/A

1.1DataRank · unranked

52 citations

Teresa Beamon, Romi Gupta, Narendra Wajapeyee

Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments

Trends in Immunology(2025)10.1016/j.it.2024.12.006

N/A

0.550DataRank · unranked

38 citations

Raj Kumar, Courtney A. Penn, Narendra Wajapeyee, Romi Gupta

UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress

NAR Cancer(2022)10.1093/narcan/zcac035

N/A

0.477DataRank · unranked

23 citations

Praveen Guruvaiah, Kiran Kumar Reddi, Suresh Bugide, Dhana Sekhar Reddy Bandi, Yvonne J. K. Edwards +3 more

Transcriptional determinants of cancer immunotherapy response and resistance

Trends in cancer(2022)10.1016/j.trecan.2022.01.008

N/A

0.449DataRank · unranked

19 citations

Amitkumar Mehta, Narendra Wajapeyee, Romi Gupta

ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE

Cell Death and Disease(2023)10.1038/s41419-023-05993-9

N/A

0.442DataRank · unranked

18 citations

Suresh Chava, Chiao‐Wang Sun, Nirupama Singh, Courtney A. Penn, Romi Gupta +1 more

ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability

Cell Death and Disease(2024)10.1038/s41419-024-06831-2

N/A

0.329DataRank · unranked

7 citations

Suresh Chava, Siva Chander Chabattula, Yvonne J. K. Edwards, Kamaljeet Singh, Romi Gupta +1 more

m6A-driven transcriptomic rewiring in tumor immune surveillance

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012744

N/A

0.292DataRank · unranked

6 citations

Patrick Ball, Romi Gupta, Narendra Wajapeyee, Parmanand Malvi

Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth

iScience(2022)10.1016/j.isci.2022.104752

N/A

0.292DataRank · unranked

6 citations

Suresh Bugide, Parmanand Malvi, Romi Gupta, Suresh Chava

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Journal of Visualized Experiments(2020)10.3791/60714-v

N/A

0.208DataRank · unranked

3 citations

Suresh Bugide, Romi Gupta, Narendra Wajapeyee, Suresh Chava

Data from Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies

(2023)10.1158/0008-5472.c.6513472.v1

N/A

0DataRank · unranked

0 citations

Romi Gupta, Narendra Wajapeyee

Exploring the therapeutic use and outcome of antibody-drug conjugates in ovarian cancer treatment

Oncogene(2025)10.1038/s41388-025-03448-3

N/A

0DataRank · unranked

21 citations

Romi Gupta, Revu V. L. Narayana

PDE7A inhibition suppresses triple-negative breast cancer by attenuating de novo pyrimidine biosynthesis

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102356

N/A

0DataRank · unranked

2 citations

Suresh Bugide, Roshan Dutta, Kiran Kumar Reddi, Yvonne J. K. Edwards, Kamaljeet Singh +3 more

Identification of the Mutational Landscape of Gynecological Malignancies

Journal of Cancer(2020)10.7150/jca.46174

N/A

0DataRank · unranked

19 citations

Romi Gupta, Suresh Chava

Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression

EMBO Molecular Medicine(2025)10.1038/s44321-025-00357-6

N/A

0DataRank · unranked

2 citations

Suresh Bugide, Parmanand Malvi, Kelly D. DeMarco, Boyang Ma, Chaitanya N. Parikh +6 more

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Journal of Visualized Experiments(2020)10.3791/60714

N/A

0DataRank · unranked

12 citations

Suresh Bugide, Romi Gupta, Narendra Wajapeyee, Suresh Chava

Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R

Oncogenesis(2020)10.1038/s41389-020-0228-x

N/A

0DataRank · unranked

28 citations

Keshab R. Parajuli, Suresh Chava, Rudradip Pattanayak, Deborah L. Della Manna, Deepmala Shrestha +5 more

Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies

Cancer Research(2021)10.1158/0008-5472.can-21-1606

N/A

0DataRank · unranked

102 citations

Romi Gupta, Narendra Wajapeyee

EZH2 inhibits NK cell–mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2102718118

N/A

0DataRank · unranked

79 citations

Romi Gupta, Michael R. Green, Narendra Wajapeyee, Suresh Bugide

Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis

Oncogenesis(2021)10.1038/s41389-021-00339-6

N/A

0DataRank · unranked

33 citations

Suresh Bugide, Yvonne J. K. Edwards, Romi Gupta, Suresh Chava

The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis

Cancers(2021)10.3390/cancers13215516

N/A

0DataRank · unranked

32 citations

Suresh Chava, Kiran Kumar Reddi, Romi Gupta, Lawrence David Mason

Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis

iScience(2022)10.1016/j.isci.2022.104211

N/A

0DataRank · unranked

11 citations

Suresh Bugide, Xuchen Zhang, Romi Gupta, Narendra Wajapeyee, Suresh Chava

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.926437

N/A

0DataRank · unranked

7 citations

Vipin Rawat, Romi Gupta, Narendra Wajapeyee, Parmanand Malvi

HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101285

N/A

0DataRank · unranked

23 citations

Suresh Chava, Guoping Cai, Kai Hu, Lihua Julie Zhu, Yvonne J. K. Edwards +4 more